Literature DB >> 32989225

G3BP1 interacts with YWHAZ to regulate chemoresistance and predict adjuvant chemotherapy benefit in gastric cancer.

Junjie Zhao1,2,3, Xuhong Fu4, Hao Chen1,2,3, Lingqiang Min1,2,3, Jie Sun1,2,3, Jingyi Yin4, Jianping Guo5, Haojie Li1,2,3, Zhaoqing Tang1,2,3, Yuanyuan Ruan6, Xuefei Wang7,8,9, Yihong Sun1,2,3, Liyu Huang10.   

Abstract

BACKGROUND: A large proportion of gastric cancer patients are susceptible to chemoresistance, while the underlying mechanism remains obscure. Stress granules (SGs) play a self-defence role for tumour cells in inhibiting chemotherapy-induced apoptosis. As an SG assembly effector, G3BP1 (Ras-GTPase-activating protein SH3 domain-binding protein) has been reported to be overexpressed in gastric cancer; thus, here we aim to explore its potent roles in gastric cancer chemoresistance.
METHODS: Kaplan-Meier analysis was used to compare survival rates in gastric cancer patients with different G3BP1 expression. The influence of G3BP1 on gastric cancer cell chemoresistance and apoptosis were evaluated by in vitro and in vivo approaches. The interaction between G3BP1 and YWHAZ was assessed by immunohistochemistry, immunoprecipitation and immunofluorescence.
RESULTS: G3BP1 was associated with the poor outcome of gastric cancer patients who received adjuvant chemotherapy. G3BP1 knockdown significantly increased the sensitivity of gastric cancer cells to chemotherapy drugs. Mechanically, cell apoptosis and pro-apoptotic-associated molecules were significantly elevated upon G3BP1 depletion. Gene co-expression network analyses identified YWHAZ as the critical interlayer of G3BP1; as a result, G3BP1 interacted with YWHAZ to sequester Bax into the cytoplasm. Clinically, G3BP1highYWHAZhigh gastric cancer patients displayed the worst outcome compared with other patients after chemotherapy.
CONCLUSIONS: The expression of G3BP1 and YWHAZ could predict the adjuvant chemotherapy benefit in gastric cancer patients.

Entities:  

Year:  2020        PMID: 32989225      PMCID: PMC7852868          DOI: 10.1038/s41416-020-01067-1

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  39 in total

1.  G3BP1 promotes DNA binding and activation of cGAS.

Authors:  Zhao-Shan Liu; Hong Cai; Wen Xue; Miao Wang; Tian Xia; Wan-Jin Li; Jia-Qing Xing; Ming Zhao; Yi-Jiao Huang; Shuai Chen; Sheng-Ming Wu; Xinzheng Wang; Xin Liu; Xue Pang; Zi-Yu Zhang; Tingting Li; Jiang Dai; Fangting Dong; Qing Xia; Ai-Ling Li; Tao Zhou; Zheng-Gang Liu; Xue-Min Zhang; Tao Li
Journal:  Nat Immunol       Date:  2018-12-03       Impact factor: 25.606

2.  Control of fetal growth and neonatal survival by the RasGAP-associated endoribonuclease G3BP.

Authors:  Latifa Zekri; Karim Chebli; Hélène Tourrière; Finn C Nielsen; Thomas V O Hansen; Abdelhaq Rami; Jamal Tazi
Journal:  Mol Cell Biol       Date:  2005-10       Impact factor: 4.272

3.  Modulation of p53 and MDM2 activity by novel interaction with Ras-GAP binding proteins (G3BP).

Authors:  M M Kim; D Wiederschain; D Kennedy; E Hansen; Z-M Yuan
Journal:  Oncogene       Date:  2007-02-05       Impact factor: 9.867

Review 4.  Apoptosis: a link between cancer genetics and chemotherapy.

Authors:  Ricky W Johnstone; Astrid A Ruefli; Scott W Lowe
Journal:  Cell       Date:  2002-01-25       Impact factor: 41.582

5.  Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology.

Authors:  Jaffer A Ajani; Thomas A D'Amico; Khaldoun Almhanna; David J Bentrem; Joseph Chao; Prajnan Das; Crystal S Denlinger; Paul Fanta; Farhood Farjah; Charles S Fuchs; Hans Gerdes; Michael Gibson; Robert E Glasgow; James A Hayman; Steven Hochwald; Wayne L Hofstetter; David H Ilson; Dawn Jaroszewski; Kimberly L Johung; Rajesh N Keswani; Lawrence R Kleinberg; W Michael Korn; Stephen Leong; Catherine Linn; A Craig Lockhart; Quan P Ly; Mary F Mulcahy; Mark B Orringer; Kyle A Perry; George A Poultsides; Walter J Scott; Vivian E Strong; Mary Kay Washington; Benny Weksler; Christopher G Willett; Cameron D Wright; Debra Zelman; Nicole McMillian; Hema Sundar
Journal:  J Natl Compr Canc Netw       Date:  2016-10       Impact factor: 11.908

Review 6.  Current adjuvant treatment modalities for gastric cancer: From history to the future.

Authors:  Leyla Kilic; Cetin Ordu; Ibrahim Yildiz; Fatma Sen; Serkan Keskin; Rumeysa Ciftci; Kezban Nur Pilanci
Journal:  World J Gastrointest Oncol       Date:  2016-05-15

7.  JNK promotes Bax translocation to mitochondria through phosphorylation of 14-3-3 proteins.

Authors:  Fuminori Tsuruta; Jun Sunayama; Yasunori Mori; Seisuke Hattori; Shigeomi Shimizu; Yoshihide Tsujimoto; Katsuji Yoshioka; Norihisa Masuyama; Yukiko Gotoh
Journal:  EMBO J       Date:  2004-04-08       Impact factor: 11.598

Review 8.  Surgical management of advanced gastric cancer: An evolving issue.

Authors:  L Marano; K Polom; A Patriti; G Roviello; G Falco; A Stracqualursi; R De Luca; R Petrioli; M Martinotti; D Generali; D Marrelli; N Di Martino; F Roviello
Journal:  Eur J Surg Oncol       Date:  2015-11-14       Impact factor: 4.424

9.  Chemotherapy for advanced gastric cancer: review and update of current practices.

Authors:  Sung Chul Park; Hoon Jai Chun
Journal:  Gut Liver       Date:  2013-07-11       Impact factor: 4.519

Review 10.  Molecular mechanisms of chemoresistance in gastric cancer.

Authors:  Wen-Jia Shi; Jin-Bo Gao
Journal:  World J Gastrointest Oncol       Date:  2016-09-15
View more
  7 in total

1.  Tumor-promoting properties of karyopherin β1 in melanoma by stabilizing Ras-GTPase-activating protein SH3 domain-binding protein 1.

Authors:  Fan Yang; Lin Li; Zhenzhen Mu; Pengyue Liu; Ying Wang; Yue Zhang; Xiuping Han
Journal:  Cancer Gene Ther       Date:  2022-07-28       Impact factor: 5.854

Review 2.  Stress Granules in the Anti-Cancer Medications Mechanism of Action: A Systematic Scoping Review.

Authors:  Mohammad Reza Asadi; Marziyeh Sadat Moslehian; Hani Sabaie; Marziye Poornabi; Elham Ghasemi; Mehdi Hassani; Bashdar Mahmud Hussen; Mohammad Taheri; Maryam Rezazadeh
Journal:  Front Oncol       Date:  2021-12-24       Impact factor: 6.244

3.  Loss of Ras GTPase-activating protein SH3 domain-binding protein 1 (G3BP1) inhibits the progression of ovarian cancer in coordination with ubiquitin-specific protease 10 (USP10).

Authors:  Mengyuan Li; Yan Tang; Xinzhao Zuo; Silin Meng; Ping Yi
Journal:  Bioengineered       Date:  2022-01       Impact factor: 3.269

4.  m6A regulator expression profile predicts the prognosis, benefit of adjuvant chemotherapy, and response to anti-PD-1 immunotherapy in patients with small-cell lung cancer.

Authors:  Zhihui Zhang; Chaoqi Zhang; Yuejun Luo; Peng Wu; Guochao Zhang; Qingpeng Zeng; Lide Wang; Zhaoyang Yang; Liyan Xue; Bo Zheng; Hua Zeng; Fengwei Tan; Qi Xue; Shugeng Gao; Nan Sun; Jie He
Journal:  BMC Med       Date:  2021-11-22       Impact factor: 8.775

5.  CircRNA-CREIT inhibits stress granule assembly and overcomes doxorubicin resistance in TNBC by destabilizing PKR.

Authors:  Xiaolong Wang; Tong Chen; Chen Li; Wenhao Li; Xianyong Zhou; Yaming Li; Dan Luo; Ning Zhang; Bing Chen; Lijuan Wang; Wenjing Zhao; Shanji Fu; Qifeng Yang
Journal:  J Hematol Oncol       Date:  2022-08-29       Impact factor: 23.168

Review 6.  The Integral Role of RNA in Stress Granule Formation and Function.

Authors:  Danae Campos-Melo; Zachary C E Hawley; Cristian A Droppelmann; Michael J Strong
Journal:  Front Cell Dev Biol       Date:  2021-05-20

7.  Lnc524369 promotes hepatocellular carcinoma progression and predicts poor survival by activating YWHAZ-RAF1 signaling.

Authors:  Wei Zheng; Guo-Liang Shen; Ke-Yang Xu; Qiao-Qiao Yin; Tian-Chen Hui; Zhe-Wen Zhou; Cheng-An Xu; Shou-Hao Wang; Wen-Hao Wu; Ling-Fei Shi; Hong-Ying Pan
Journal:  World J Gastrointest Oncol       Date:  2022-01-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.